Protein C system in preterm babies with chronic lung disease: Prospective study

Area of Science:

• Neonatal Medicine
• Pulmonary Medicine
• Hematology

Background:

• Chronic lung disease (CLD) is a significant neonatal pulmonary condition linked to inflammation.
• Protein C (PC) pathway factors, including protein S (PS) and thrombomodulin (TM), are potential indicators of pulmonary injury.
• The role of these factors in the development of CLD among very low birthweight (VLBW) preterm infants requires further investigation.

Purpose of the Study:

• To investigate whether PC pathway-related factors (TM, PC, PS) at birth can predict the development of CLD in preterm infants with VLBW.

Main Methods:

• Plasma samples were collected at birth from 26 VLBW preterm infants (13 with CLD, 13 without).
• Levels of TM, PC, and PS were measured.
• Prospective analysis examined the relationship between these factors and CLD development.

Main Results:

• Infants with CLD had significantly higher TM levels at birth compared to those without CLD (P = 0.013).
• TM levels correlated with gestational age and duration of mechanical ventilation.
• Covariance analysis indicated that gestational age, not TM level at birth, was significantly associated with TM levels, and consequently, CLD development was not predicted by TM at birth.

Conclusions:

• Thrombomodulin, PC, and PS levels measured at birth are not predictive of CLD development in preterm infants with VLBW.
• These protein C pathway factors do not serve as reliable biomarkers for predicting CLD in this vulnerable population.